Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
IsoPlexis Corporation ISO
$0.76
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
30283577.00000000
-
week52high
3.84
-
week52low
0.60
-
Revenue
16761000
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
-2.55000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 ноя 2022 г. в 13:30
Описание компании
IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| SVB Leerink | Market Perform | Outperform | 11 авг 2022 г. |
| Morgan Stanley | Equal-Weight | Overweight | 11 авг 2022 г. |
| SVB Leerink | Outperform | Outperform | 12 мая 2022 г. |
| Morgan Stanley | Overweight | Overweight | 12 мая 2022 г. |
| Morgan Stanley | Overweight | Overweight | 15 февр 2022 г. |
| SVB Leerink | Market Perform | Market Perform | 11 ноя 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 05 янв 2023 г. |
| SVB Leerink | Market Perform | Market Perform | 22 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Conley John G. | D | 0 | 20000 | 30 янв 2023 г. |
| Conley John G. | A | 100752 | 20000 | 30 янв 2023 г. |
| Conley John G. | A | 80752 | 16000 | 30 янв 2023 г. |
| SHAMIR NACHUM | A | 50253 | 40000 | 31 авг 2022 г. |
| SHAMIR NACHUM | A | 10253 | 10253 | 30 авг 2022 г. |
| Strahley John | A | 65000 | 10000 | 25 авг 2022 г. |
| Rew Richard W. II | A | 20000 | 20000 | 25 авг 2022 г. |
| Mackay Sean | A | 914366 | 15000 | 25 авг 2022 г. |
| SHAMIR NACHUM | A | 196842 | 196842 | 22 авг 2022 г. |
| Mackay Sean | D | 19000 | 61000 | 19 авг 2022 г. |
Новостная лента
Why Is IsoPlexis (ISO) Stock Up 80% Today?
InvestorPlace
22 дек 2022 г. в 10:22
IsoPlexis (NASDAQ: ISO ) stock is jumping more than 80% today on news that the company will join forces with Berkeley Lights (NASDAQ: BLI ). The two names will combine into a new company called PhenomeX.
IsoPlexis Corporation (ISO) Q3 2022 Earnings Call Transcript
Seeking Alpha
11 ноя 2022 г. в 13:57
IsoPlexis Corporation (NASDAQ:ISO ) Q3 2022 Earnings Conference Call November 10, 2022 5:30 PM ET Company Participants Carrie Mendivil - IR Sean Mackay - CEO John Strahley - CFO Conference Call Participants Jordan Adler - Evercore ISI Joe Giordano - Cowen Michael Jones - SVB Securities Edmund Tu - Morgan Stanley Operator Good day and thank you for standing by. Welcome to the IsoPlexis Third Quarter 2022 Earnings Conference Call.
IsoPlexis to Participate in Upcoming Investor Conferences
GlobeNewsWire
09 ноя 2022 г. в 07:00
BRANFORD, Conn., Nov. 09, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced it will be participating in the following investor conferences.
IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022
GlobeNewsWire
19 окт 2022 г. в 07:00
BRANFORD, Conn., Oct. 19, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced it will report financial results for the third quarter 2022 before market open on Thursday, November 10, 2022. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
IsoPlexis to Participate in the Morgan Stanley Global Healthcare Conference
GlobeNewsWire
31 авг 2022 г. в 07:00
BRANFORD, Conn., Aug. 31, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced it will be participating in the upcoming Morgan Stanley Global Healthcare Conference in New York, NY.